GUARDANT HEALTH, INC. Increase (Decrease) in Accounts Receivable
GUARDANT HEALTH, INC. (GH) reported Increase (Decrease) in Accounts Receivable of $5.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-30
- GUARDANT HEALTH, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $6.89M, a 51.88% decline year-over-year.
- GUARDANT HEALTH, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$942.00K, a 115.40% decline year-over-year.
- GUARDANT HEALTH, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $22.20M, a 2.30% increase year-over-year.
- GUARDANT HEALTH, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$14.45M.
- GUARDANT HEALTH, INC. increase (decrease) in accounts receivable for fiscal 2025 was $28.18M, a 31.73% increase from fiscal 2024.
- GUARDANT HEALTH, INC. increase (decrease) in accounts receivable for fiscal 2024 was $21.39M.
- GUARDANT HEALTH, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$8.38M.
- GUARDANT HEALTH, INC. increase (decrease) in accounts receivable for fiscal 2022 was -$375.00K, a 100.85% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $5.94M 10-Q · filed 2026-07-30 | $28.15M derived: sum of 3 quarters · filed 2026-07-30 | $13.69M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$942.00K 10-Q · filed 2026-05-07 | $21.26M derived: sum of 2 quarters · filed 2026-05-07 | $6.81M derived: sum of 3 quarters · filed 2026-05-07 | $21.12M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $22.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $7.75M derived: sum of 2 quarters · filed 2026-02-19 | $22.06M derived: sum of 3 quarters · filed 2026-07-30 | $28.18M 10-K · filed 2026-02-19 |
| 2025-09-30 | -$14.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$144.00K derived: sum of 2 quarters · filed 2026-07-30 | $5.97M 10-Q · filed 2025-10-29 | $27.68M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $14.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $20.43M 10-Q · filed 2026-07-30 | $42.13M derived: sum of 3 quarters · filed 2026-07-30 | $30.08M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $6.12M 10-Q · filed 2026-05-07 | $27.82M derived: sum of 2 quarters · filed 2026-05-07 | $15.77M derived: sum of 3 quarters · filed 2026-05-07 | $31.72M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $21.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.65M derived: sum of 2 quarters · filed 2026-02-19 | $25.61M derived: sum of 3 quarters · filed 2026-02-19 | $21.39M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$12.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $3.90M derived: sum of 2 quarters · filed 2025-10-29 | -$316.00K 10-Q · filed 2025-10-29 | -$334.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $15.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $11.74M 10-Q · filed 2025-07-30 | $11.72M derived: sum of 3 quarters · filed 2026-02-19 | $14.05M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$4.22M 10-Q · filed 2025-04-30 | -$4.24M derived: sum of 2 quarters · filed 2026-02-19 | -$1.90M derived: sum of 3 quarters · filed 2026-02-19 | -$249.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.32M derived: sum of 2 quarters · filed 2026-02-19 | $3.97M derived: sum of 3 quarters · filed 2026-02-19 | -$8.38M 10-K · filed 2026-02-19 |
| 2023-09-30 | $2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $3.99M derived: sum of 2 quarters · filed 2024-11-06 | -$8.36M 10-Q · filed 2024-11-06 | $2.70M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$10.70M 10-Q · filed 2024-08-07 | $361.00K derived: sum of 3 quarters · filed 2025-02-20 | -$8.71M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | -$12.35M 10-Q · filed 2024-05-09 | -$1.29M derived: sum of 2 quarters · filed 2025-02-20 | -$10.37M derived: sum of 3 quarters · filed 2025-02-20 | $575.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $11.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.98M derived: sum of 2 quarters · filed 2025-02-20 | $12.92M derived: sum of 3 quarters · filed 2025-02-20 | -$375.00K 10-K · filed 2025-02-20 |
| 2022-09-30 | -$9.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.87M derived: sum of 2 quarters · filed 2023-11-06 | -$11.43M 10-Q · filed 2023-11-06 | $25.48M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $10.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$2.35M 10-Q · filed 2023-08-03 | $34.55M derived: sum of 3 quarters · filed 2024-02-22 | $41.63M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$13.30M 10-Q · filed 2023-05-09 | $23.61M derived: sum of 2 quarters · filed 2024-02-22 | $30.69M derived: sum of 3 quarters · filed 2024-02-22 | $36.31M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $36.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $43.98M derived: sum of 2 quarters · filed 2024-02-22 | $49.61M derived: sum of 3 quarters · filed 2024-02-22 | $44.35M 10-K · filed 2024-02-22 |
| 2021-09-30 | $7.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $12.71M derived: sum of 2 quarters · filed 2022-11-03 | $7.45M 10-Q · filed 2022-11-03 | $24.49M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $5.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $368.00K 10-Q · filed 2022-08-04 | $17.41M derived: sum of 3 quarters · filed 2023-02-23 | $12.72M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$5.26M 10-Q · filed 2022-05-05 | $11.78M derived: sum of 2 quarters · filed 2023-02-23 | $7.10M derived: sum of 3 quarters · filed 2023-02-23 | $24.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $17.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $12.36M derived: sum of 2 quarters · filed 2023-02-23 | $5.28M derived: sum of 3 quarters · filed 2023-02-23 | $5.46M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$4.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$11.76M derived: sum of 2 quarters · filed 2021-11-04 | -$11.58M 10-Q · filed 2021-11-04 | -$3.28M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$7.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$6.89M 10-Q · filed 2021-08-05 | $1.40M derived: sum of 3 quarters · filed 2022-02-24 | $729.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $179.00K 10-Q · filed 2021-05-06 | $8.48M derived: sum of 2 quarters · filed 2022-02-24 | $7.80M derived: sum of 3 quarters · filed 2022-02-24 | $19.18M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $7.62M derived: sum of 2 quarters · filed 2022-02-24 | $19.00M derived: sum of 3 quarters · filed 2022-02-24 | $7.39M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$674.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $10.70M derived: sum of 2 quarters · filed 2020-11-05 | -$908.00K 10-Q · filed 2020-11-05 | $20.14M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $11.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$234.00K 10-Q · filed 2020-08-06 | $20.82M derived: sum of 3 quarters · filed 2021-02-25 | $24.89M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$11.61M 10-Q · filed 2020-05-07 | $9.44M derived: sum of 2 quarters · filed 2021-02-25 | $13.52M derived: sum of 3 quarters · filed 2021-02-25 | $11.92M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $21.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $25.13M derived: sum of 2 quarters · filed 2021-02-25 | $23.53M derived: sum of 3 quarters · filed 2021-02-25 | $22.90M 10-K · filed 2021-02-25 |
| 2018-09-30 | $4.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.48M derived: sum of 2 quarters · filed 2019-11-07 | $1.85M 10-Q · filed 2019-11-07 | $7.30M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$2.22M 10-Q · filed 2019-08-07 | $3.22M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2018-03-31 | -$623.00K 10-Q · filed 2019-05-10 | $4.82M derived: sum of 2 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $5.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $9.29M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $3.85M 10-Q · filed 2018-11-19 | |||
| 2016-12-31 | $2.79M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |